FOX BIZ NEWS: Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group

Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group



If Phase 1 is successful, Novavax will follow up with Phase 2 in multiple countries, including the U.S.

via FOX BUSINESS NEWS https://ift.tt/3gnTgsg